Therapeutic applications of Fenugreek - Fenugreek

Alternative Medicine Review, Feb, 2003 by Ethan Basch, Catherine Ulbricht, Grace Kuo, Philippe Szapary, Michael Smith

(40.) Rao PU, Sesikeran B, Rao PS, et al. Short term nutritional and safety evaluation of fenugreek. Nutr Res 1996;16:1495-1505.

(41.) Yale JF. Prevention of type 2 diabetes. Int J Clin Pract Suppl 2000;113:35-39.

(42.) No authors listed. Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.

(43.) Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-359.

Catherine Ulbricht, PharmD--Senior Attending Pharmacist,
Massachusetts General Hospital; Adjunct Clinical Professor,
Massachusetts College of Pharmacy; Assistant Clinical Professor,
Northeastern University; and Assistant Clinical Professor,
University of Rhode Island.
Correspondence address: 1130 Massachusetts Avenue,
Cambridge, MA 02138-5204;
e-mail: kate@naturalstandard.com

Ethan Basch, MD--Editorial Board of Harvard Health Publications
and the Journal of Herbal Pharmacotherapy,; Chief Editor,
Massachusetts General Hospital Primer of Outpatient Medicine;
Advisory Boards, Integrative Medicine Alliance and CancerSource

Michael Smith, ND--Associate Dean for Research at the Canadian
College of Naturopathic Medicine; serves on National Advisory
Group on Complementary and Alternative Medicine and HIV/AIDS
panel.

Philippe Szapary, MD--Assistant Professor of Medicine, Division of
General Internal Medicine, University of Pennsylvania where he
conducts clinical trials of CAM therapies in cardiovascular disease.

Grace Kuo, PharmD--Faculty, Baylor College of Medicine; teaches
at the University of Houston College of Pharmacy.